<DOC>
	<DOCNO>NCT02528188</DOCNO>
	<brief_summary>The purpose study compare long-term joint safety efficacy ( pain relief ) investigational study drug , tanezumab compare non-steroidal anti inflammatory drug ( NSAIDs ) subject osteoarthritis hip knee .</brief_summary>
	<brief_title>Long Term Safety Efficacy Study Tanezumab Subjects With Osteoarthritis Hip Knee</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Osteoarthritis , Hip</mesh_term>
	<mesh_term>Anti-Inflammatory Agents , Non-Steroidal</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<mesh_term>Naproxen</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<criteria>A diagnosis osteoarthritis index hip knee base American College Rheumatology criterion Kellgren Lawrence X ray Grade 2 diagnosed Central Reader Currently receive stable dose regimen oral NSAID ( naproxen , celecoxib , diclofenac , aceclofenac , loxoprofen , ibuprofen , meloxicam , nabumetone , sulindac ketoprofen ) describe protocol along history insufficient pain relief , inability tolerate contraindication take acetaminophen , tramadol opioid treatment . Subjects must also maintain stabilized , protocol specify NSAID dose regimen least final 2 3 week Screening period WOMAC Pain subscale score least 5 index knee hip Screening Be willing discontinue non study pain medication osteoarthritis use prohibit pain medication throughout duration study Female subject childbearing potential must agree comply protocol specify contraceptive requirement Subjects exceed protocol define BMI body weight limit History disease specify protocol ( eg , inflammatory joint disease , crystalline disease gout pseudogout ) may involve index joint could interfere efficacy assessment Radiographic evidence protocol specify bone joint condition screen radiograph determine central radiology reviewer A history osteonecrosis osteoporotic fracture History significant trauma surgery knee , hip shoulder within previous year Planned surgical procedure duration study Presence condition ( eg , fibromyaliga , radiculopathy ) associate moderate severe pain may confound assessment self evaluation osteoarthritis pain Signs symptom carpal tunnel syndrome year prior Screening Considered unfit surgery base upon American Society Anesthesiologists physical classification system surgery grading , subject would willing undergo joint replacement surgery require Contraindications magnetic resonance image History intolerance hypersensitivity oral NSAID ( naproxen , celecoxib diclofenac ) subject could randomize receive excipients existence medical condition use concomitant medication use NSAID contraindicate History intolerance hypersensitivity acetaminophen excipients existence medical condition use concomitant medication use acetaminophen contraindicate Use prohibit medication without appropriate washout period prior Screening Initial Pain Assessment Period History cancer within 5 year Screening , except cutaneous basal cell squamous cell cancer resolve excision Subjects sign symptom clinically significant cardiac disease describe protocol Diagnosis transient ischemic attack 6 month prior Screening , diagnosis stroke residual deficit would preclude completion require study activity History , diagnosis , sign symptom clinically significant neurological disease limit peripheral autonomic neuropathy History , diagnosis , sign symptom clinically significant psychiatric disorder History know alcohol , analgesic drug abuse within 2 year Screening Previous exposure exogenous NGF antiNGF antibody History allergic anaphylactic reaction therapeutic diagnostic monoclonal antibody IgG fusion protein Poorly control hypertension define protocol take antihypertensive stable least 1 month prior Screening Evidence protocol define orthostatic hypotension Screening Disqualifying score Survey Autonomic Symptoms questionnaire Screening Screening AST , ALT , serum creatinine HbA1c value exceed protocol define limit Presence drug abuse screen urine toxicology panel Positive hepatitis B , hepatitis C HIV test result indicative current infection Participation investigational drug study within protocol define time limit Pregnant , breastfeed female subject childbearing potential unwilling unable follow protocol require contraceptive requirement Other severe acute chronic medical psychiatric condition laboratory abnormality judgment investigator , would make subject inappropriate entry study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>